Press Releases



MVision AI is delighted to announce that we have received our 2nd order for the Republic of Ireland from St. Luke’s Radiation Oncology Network (SLRON)

Finland, Helsinki, February 19, 2024 The contract for installing Contour+ Guideline Based AI Segmentation tool has been won through the public tender process and implies a three-year agreement for 5,000 scans per year. This order comes in quick succession following MVision AI's successful award of the tender from the Republic…

Press Releases


MVision AI Announces Partnership with Medron Medical Systems (Canada)

HELSINKI, Finland - January 22, 2024 MVision AI, a premier software service provider of GBS™ (Guideline-Based Segmentation) solution for same-day radiotherapy treatment planning, proudly announces a new distribution partnership with Medron Medical Systems, a leading health equipment provider in Canada. This collaboration follows the receipt of Medical Device License (MDL)…

Press Releases


The world’s first comprehensive GBS™ solution for radiation therapy cancer treatment is now available for implementation in Canadian clinics

HELSINKI, Finland - January 22, 2024 MVision AI announces first Health Canada Medical Device License for MVision AI Segmentation (Contour+).  In conjunction with Guide and Verify, Contour+ stands as a unique solution covering all the essential needs of radiotherapy departments, offering a more comprehensive approach to staff training and patient…

Press Releases


MVision AI and Institut de Cancérologie de Lorraine (ICL, Nancy) announce the first installation of unique Guide and Verify solutions for cancer treatment in France

HELSINKI, Finland - November 24, 2023 Institut de CancĂ©rologie de Lorraine (ICL) in Nancy (France) has been a MVision AI customer since the installation of Contour+ in January 2023. This year, the values of using Guideline-Based AI Segmentation in daily practice have been prominently featured in several French media outlets…

Press Releases


MVision AI is proud to announce the installation of its Contour+ at Nemocnica Bory Hospital in Slovakia

HELSINKI, Finland - October 27, 2023 MVision AI has been chosen as the preferred provider of an auto-contouring solution (Contour+) for the radiation therapy department, under the leadership of MUDr. Margita Pobijáková, PhD. Additionally, the company is an integral part of the Oncology program, alongside Elekta Linac and the first…

Press Releases


MVision AI is proud to announce the launch of the world’s first comprehensive Guideline-Based Segmentation (GBS™) solution for responsible radiation therapy contouring

HELSINKI, Finland - September 29, 2023 The launch of MVision AI’s GBS™ solution is timed to coincide with the release of two new products - Guide and Verify. Guide empowers clinical teams to competently review AI-generated structures, thereby helping them to refine their contouring skills. Our solution offers a library…

Press Releases


Press Release: MVision AI is selected to provide its Contour+ solution by the Republic of Ireland’s Health Service Executive (HSE) for its first installation in the country

HELSINKI, Finland - September 14, 2023 MVision AI is experiencing ongoing and rapid growth within the health service sector globally. The company is delighted to announce that we have successfully been awarded the tender from the Republic of Ireland’s Health Service Executive (HSE) for the installation of our Contour+ auto…

Press Releases


Press Release: MVision AI launches Contour+ auto-contouring to facilitate standardization and shorten time to treatment for cancer radiotherapy

HELSINKI, Finland - August 24, 2023MVision AI is proud to announce the new software release version 1.2.4 of its guideline-based automatic segmentation service. Along with new contouring models and advanced Region-Of-Interest (ROI) operations, MVision AI’s outstanding contouring product is being rebranded. The introduction of Contour+ extends clinical applications and elevates…

Press Releases


Press Release: MVision AI raises 5.4M€ to make same-day cancer treatment the new standard

HELSINKI, Finland - March 23, 2023 MVision AI raises 5.4M€ to make same-day cancer treatment the new standard MVision AI is the first cloud-based AI-powered radiotherapy planning solution for treating cancer. MVision uses artificial intelligence to automate cancer treatments with its unique automatic segmentation tool. The next-generation technology speeds up…

Press Releases


Distribution partnership agreement between MVision AI and Tecnosan

Finland, Helsinki, December 14, 2022 – MVision AI, the leading provider of AI-powered Guideline Based Segmentation solution for Radiotherapy planning and Tecnosan, advanced healthcare technology for radiotherapy and medical physics supplier in Italy announced cooperation and signing of a new Distribution partnership agreement. Both companies will closely cooperate on current…

Press Releases


MVision AI Receives FDA 510(k) Clearance for Guideline-Based Segmentation Radiotherapy Software

Helsinki, 31st of May, 2022 - MVision AI announces that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for guideline-based, AI-powered software for automatic segmentation for radiotherapy. (more…)

News, Press Releases


MVision’s Guideline-Based AI Segmentation is Available in the EduCase Platform

Helsinki - 19th of January, 2022 - MVision AI, the leading provider of the guideline-based solution, collaborates with EduCase, the global leader in web-based education designed to support contouring skill instructions for radiation oncologists. EduCase is a computer-based training tool developed by RadOnc eLearning Center, LLC., to assist the development…

News, Press Releases

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI